Cargando…

Revisiting mTOR and Epithelial–Mesenchymal Transition

Detalles Bibliográficos
Autores principales:	Herrerias, Mariana M., Budinger, G. R. Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258817/ https://www.ncbi.nlm.nih.gov/pubmed/32228391 http://dx.doi.org/10.1165/rcmb.2020-0109ED

Ejemplares similares

The Integrated Stress Response Links Muc5b to Pulmonary Fibrosis
por: Herrerias, Mariana M., et al.
Publicado: (2022)

Tenascin-C promotes epithelial-to-mesenchymal transition and the mTOR signaling pathway in nasopharyngeal carcinoma
por: Cheng, Xiang, et al.
Publicado: (2021)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

Lkb1 and Pten Synergise to Suppress mTOR-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in the Mouse Bladder
por: Shorning, Boris Y., et al.
Publicado: (2011)

mTOR Signaling in Metabolism and Cancer
por: Huang, Shile
Publicado: (2020)

Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
por: Lamouille, Samy, et al.
Publicado: (2007)

Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition
por: Sanookpan, Kittipong, et al.
Publicado: (2021)

ROS, Klotho and mTOR in cardiorenal aging
por: Daneshgar, Nastaran, et al.
Publicado: (2020)

Exploiting the mTOR paradox for disease prevention
por: Iglesias-Bartolome, Ramiro, et al.
Publicado: (2012)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Age-related mTOR in gynaecological cancers
por: Bajwa, Preety, et al.
Publicado: (2017)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway
por: Jia, Yuan-yuan, et al.
Publicado: (2021)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging
por: Das, Anindita, et al.
Publicado: (2017)

RAMS11 promotes CRC through mTOR-dependent inhibition of autophagy, suppression of apoptosis, and promotion of epithelial-mesenchymal transition
por: Islam Khan, Md Zahirul, et al.
Publicado: (2021)

Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
por: Li, Wenfeng, et al.
Publicado: (2022)

mTOR pathway in familial focal epilepsies
por: Ribierre, Théo, et al.
Publicado: (2016)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

microRNAs calibrate T cell responses by regulating mTOR
por: Merkenschlager, Matthias, et al.
Publicado: (2015)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging 2018
por: Das, Anindita, et al.
Publicado: (2019)

mTOR Signaling Network in Cell Biology and Human Disease
por: Yu, Jane J., et al.
Publicado: (2022)

Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition
por: Ye, Mujie, et al.
Publicado: (2020)

Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling
por: Yang, Zhao, et al.
Publicado: (2016)

The PI3K-AKT-mTOR signaling pathway mediates the cytoskeletal remodeling and epithelial-mesenchymal transition in bladder outlet obstruction
por: Zhang, Zhaoxia, et al.
Publicado: (2023)

Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2(+/−) Mice
por: Jones, Ashley T., et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway
por: Wang, Meng-He, et al.
Publicado: (2018)

Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT/mTOR signaling pathway
por: Li, Jingpei, et al.
Publicado: (2021)

Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
por: Yeh, Yen-Hsiu, et al.
Publicado: (2018)

Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway
por: Zhang, Dong, et al.
Publicado: (2017)

Tripterygium glycoside suppresses epithelial-to-mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway
por: Tao, Mei, et al.
Publicado: (2021)

NANOG regulates epithelial–mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV‐3 and A2780 cells
por: Yun, Hee, et al.
Publicado: (2022)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k6htdncfdoltfd2d5rcnt3ons5